Overcoming Immune Dysregulation with Immunoengineered Nanobiomaterials

Area of Science:

• Immunology and Nanotechnology
• Biomedical Engineering

Background:

• The immune system's complexity necessitates precise regulation to maintain homeostasis.
• Dysregulated immune responses are implicated in numerous inflammation-driven diseases like cancer and autoimmune disorders.

Purpose of the Study:

• To review recent advancements in nanobiomaterials for modulating immune responses.
• To highlight the potential of rationally designed nanobiomaterials in treating immune dysregulation.

Main Methods:

• Engineering of nanoscale biomaterials (nanobiomaterials).
• Designing nanobiomaterials to interact with and direct immune cells and molecular factors.
• Targeting specific inflammatory cells and biochemical pathways.

Main Results:

• Nanobiomaterials demonstrate potential as customizable platforms for immune system modulation.
• Rational design enables targeted interaction with immune components.
• Development of novel strategies to redirect or inhibit inflammation.

Conclusions:

• Nanobiomaterials represent a promising therapeutic avenue for immune dysregulation.
• Engineered nanobiomaterials can be utilized to control inflammatory processes.
• This approach holds potential for treating a range of pathologies driven by inflammation.